<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>15</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2014</Year>
					<Month>02</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Association Between VDR Polymorphisms and Breast Cancer: An Updated and Comparative Meta-analysis of Crude and Adjusted Odd Ratios</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>847</FirstPage>
			<LastPage>853</LastPage>
			<ELocationID EIdType="pii">28673</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>1970</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</History>
		<Abstract>There is a lot of debate on the relationship between vitamin D receptor polymorphisms and risk of breastcancer. Herein, we quantitatively analyzed the published case-control studies on this relationship by metaanalysis,performing a bibliographic search from Pubmed and CNKI up to July 31, 2013. The included casecontrolstudies for Fok1, Bsm1, Taq1, Apa1, Cdx2 and Poly-A were 16, 19, 20, 10, 4, 6, respectively. Crude andadjusted odd ratios and 95% confidence intervals were calculated to present and compare the strength of anyassociations. The results of combined analyses indicated that Fok1, Bsm1, Apa1, Cdx2 and Poly-A were notsignificantly associated with the risk of breast cancer. In contrast, the tt genotype of Taq1 was a modest riskfactor for breast cancer development (tt vs. TT: OR = 1.21, 95% CI: 1.01-1.44). To further confirm the aboveresults, adjusted effects for the six polymorphisms were pooled based on adjusted ORs reported in the originalstudies. Adjusted ORs of Fok1, Apa1, Cdx2 and Poly-A were similar to the crude ORs. However, Bsm1 and Taq1showed inconsistent results. For Bsm1, OR for BB vs. bb was 0.85, 95% CI: 0.74-0.98; for Taq1, OR for tt vs.TT was 1.03, 95% CI: 0.92-1.15, and not associated with risk. Subgroup analyses for crude ORs showed someassociation between Bsm1, Taq1 and breast cancer in Caucasians only, but for adjusted ORs, no associationswere found. This meta-analysis suggests that the roles that Fok1, Apa1, Cdx2 and Poly-A polymorphisms play inbreast cancer risk are negligible, with Bsm1 and Taq1 as possible exceptions. To be conservative, we still assumedthat they may play a modest role in determining breast cancer risk. Further studies are needed to validate ourfindings.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Vitamin D receptor</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Polymorphism</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">breast cancer</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">risk</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Meta-analysis</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_28673_2feb8d98c5ab268b19423964e5b15f71.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
